12.07.2015 Views

Conference Program - ABRF 2011 - Association of Biomolecular ...

Conference Program - ABRF 2011 - Association of Biomolecular ...

Conference Program - ABRF 2011 - Association of Biomolecular ...

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Vendor PresentationsSunday, February 20 — 12:00 pm – 1:30 pmAlyssum Room, Level 3Exhibit Booth: 214Moving Beyond ProteomicsSpeaker: Detlev Suckau, Bruker Daltonik GmbHIn current proteomics studies as well as biopharmaceutical developmentand characterization, post-translational modificationsobtain increasing attention. Amongst these, glycosylation isprominent but the lack <strong>of</strong> bioinformatics solutions slowed downthe analysis <strong>of</strong> glycoproteins in both, the biopharmaceutical industryas well as in proteomics studies.In this seminar, we introduce new solutions that include a newglycoprotein and glycoproteomics enabling bioinformatics platformand show examples from selected glycoprotein characterizationsincluding glycan and direct glycopeptide analysis usingBrukers leading ESI-MSn and MALDI platforms.Dedicated solutions for the development and quality control <strong>of</strong>Biologicals and Biosimilars will be described that show you howto rapidly characterize therapeutic proteins with the confidencethat is derived from the high specificity <strong>of</strong> Brukers ultra-highresolution QTOF maXis.As a further extension <strong>of</strong> classical protein characterization andvalidation workflows, we describe recent advances in Top-Downprotein characterization tools that will make your C- and N-terminaldefinitions specific and rapid. The ESI-ETD and MALDITop-Down Sequencing approaches will also forward your proteomicsresearch as they provide simultaneous access to PTManalysis, protein is<strong>of</strong>orm differentiation and proteolytic regulationevents that are not addressed with current technologies.Grand Oaks Ballroom,Rooms N&O, Level 2Exhibit Booth: 71412:00 pm – 12:30 pmAdvances in Sample Preparation <strong>of</strong> LowAbundant Proteins using Magnetic BeadsSpeaker: Helena Hedlund, Global Product Manager, GEHealthcare Life SciencesLow abundant proteins are <strong>of</strong>ten biologically important butdifficult to detect. Some proteins are present in a few copieswhereas others have a short transient presence. To be able toincrease the detection and identification rate, efficient samplepreparation methods are necessary. We have combined establishedaffinity chromatography methods with magnetic beadtechnology for the enrichment <strong>of</strong> such challenging proteins. Inthe first study changes in tyrosine phoshorylation in cancer cellsupon drug treatment was investigated. Immmonoprecipitationusing Protein G Mag Sepharose TM was used for enrichment <strong>of</strong>phosphorylated proteins prior to a 2-D DIGE experiment. Theeffect <strong>of</strong> the treatment will be presented as well as protein identificationfrom MS analysis.In the second study screening for optimal purification conditionsfor a number <strong>of</strong> integral membrane proteins was performed. Vitalparameters as choice <strong>of</strong> detergent wash and elution bufferconcentrations were evaluated. All experiments were done usingNi2+-charged His Mag Sepharose Ni. Results from screeningfor several detergents gave reliable results that could be fed int<strong>of</strong>urther scale-up experiments. The magnetic bead format simplifiedand shortened the handling procedures through-out thesetwo different workflows.Vendor Presentations12:30 pm – 1:00 pmQuantitative Western Blotting withAmersham TM ECL TM PrimeSpeaker: Maria Winkvist, Scientist, GE Healthcare LifeSciencesWestern blotting is a well established technique in life scienceresearch. Traditionally the technique has been restricted toqualitative protein analysis. However, development <strong>of</strong> refineddetection methods and reagents has opened up the possibilityto use the technique in quantitative analysis, for accurate monitoring<strong>of</strong> small changes in protein abundance and for detection<strong>of</strong> posttranslational modifications.120 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!